NASDAQ · Analyst Forecast

DexCom, Inc. (DXCM) Stock Forecast & Price Target

$82.23 NASDAQ: DXCM Market Cap $30.67B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering DexCom, Inc. (DXCM), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For DexCom, Inc., analysts forecast revenue rising from $4.65B in 2025 to $7.82B in 2030; the average estimate for 2030 earnings per share is $4.95; with published estimates ranging from $4.86 to $5.05; 22 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$82.23
Consensus targetThe average of the price targets analysts have published.$97.85
Median targetThe middle target, less affected by a single outlier.$96.00
Highest targetThe most optimistic published target.$115.00
Lowest targetThe most pessimistic published target.$86.00
Difference from priceHow far the consensus target sits from today’s price.+19.0%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$4.61B$4.65B$4.67B17
2026$5.21B$5.23B$5.25B21
2027$5.68B$5.77B$5.87B21
2028$6.17B$6.40B$6.59B22
2029$6.97B$7.08B$7.19B14
2030$7.70B$7.82B$7.94B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025$2.01$2.06$2.0917
2026$2.47$2.70$2.7721
2027$2.82$3.14$3.2821
2028$2.88$3.71$3.9922
2029$4.21$4.29$4.3714
2030$4.86$4.95$5.0511

DexCom, Inc. (DXCM) forecast — frequently asked questions

What is the analyst price target for DexCom, Inc.?

Analysts covering DexCom, Inc. (DXCM) have a consensus price target of $97.85, 19.0% above the current price of $82.23. Published targets range from $86.00 to $115.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for DexCom, Inc.'s earnings?

The average analyst estimate for DexCom, Inc. (DXCM) earnings per share in 2030 is 4.95, with individual estimates between 4.86 and 5.05.

How much revenue is DexCom, Inc. expected to make?

Analysts forecast DexCom, Inc. (DXCM) revenue of $7.82B in 2030, based on 11 published estimates.

How many analysts cover DXCM?

22 analysts contribute estimates for DexCom, Inc. (DXCM). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastPHG forecastZBH forecastGKOS forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.